Table 7.
Drugs | Mechanism |
---|---|
TGF related drugs | |
LY3022859 ( 124 ) | Inhibition of TGF-β receptor-mediated activation of transforming growth factor-β signaling. |
Fresolimumab ( 125 ) | Interfering With Ligand-Receptor Interactions. |
264RAD ( 126 ) | Blocks integrin-mediated TGF-β activation to target the TGF-β signaling pathway. |
TNF-related drugs | |
Infliximab,
Adalimumab, Golimumab |
Inhibits binding of TNF to its receptors to neutralize activation of TNFR1 and TNFR2. |
Etanercept | Prevents TNF binding to TNFR2. |
Certolizumab pegol | Selectively neutralize TNF-α. |